|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.00314601
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.0012039
|
|
|
CEACAM5
|
[NCBI]
|
0.00103018
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.00101245
|
|
|
RA
|
[NCBI]
|
0.000499553
|
|
|
MBP
|
[NCBI]
|
0.000461724
|
|
|
TG
|
[NCBI]
|
0.000304382
|
|
|
MG
|
[NCBI]
|
0.00020412
|
|
|
rheumatoid factor igm idiotypes
|
[NCBI]
|
0.000108987
|
|
|
MAG
|
[NCBI]
|
0.000104677
|
|
|
CF
|
[NCBI]
|
0.000100337
|
|
|
VEGF
|
[NCBI]
|
9.57251e-05
|
|
|
AD
|
[NCBI]
|
8.47985e-05
|
|
|
colchicine resistance
|
[NCBI]
|
8.13005e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
8.13005e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
7.81891e-05
|
|
|
CEACAM1
|
[NCBI]
|
6.93977e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
6.08216e-05
|
|
|
h-y antigen receptor
|
[NCBI]
|
5.92085e-05
|
|
|
galactosemia
|
[NCBI]
|
5.5464e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
5.52614e-05
|
|
|
TPO
|
[NCBI]
|
5.49337e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
5.19937e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
4.92088e-05
|
|
|
CTLN2
|
[NCBI]
|
4.46412e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
4.35076e-05
|
|
|
scheie syndrome
|
[NCBI]
|
4.27214e-05
|
|
|
EGFR
|
[NCBI]
|
4.18556e-05
|
|
|
hemophilia a
|
[NCBI]
|
4.12795e-05
|
|
|
KRT7
|
[NCBI]
|
4.1022e-05
|
|
|
CMD3B
|
[NCBI]
|
3.94001e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
3.79445e-05
|
|
|
APC
|
[NCBI]
|
3.61178e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
3.53496e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
3.53496e-05
|
|
|
SNAPC1
|
[NCBI]
|
3.46266e-05
|
|
|
trophoblast-lymphocyte crossreactive antigen
|
[NCBI]
|
3.46266e-05
|
|
|
MAGEF1
|
[NCBI]
|
3.46266e-05
|
|
|
hr44 antigen
|
[NCBI]
|
3.46266e-05
|
|
|
acidic nucleoplasmic dna-binding protein 1, xenopus, homolog of
|
[NCBI]
|
3.46266e-05
|
|
|
RNASE6
|
[NCBI]
|
3.46266e-05
|
|
|
blood group, p system
|
[NCBI]
|
3.41836e-05
|
|
|
JARID1D
|
[NCBI]
|
3.36435e-05
|
|
|
FBS
|
[NCBI]
|
3.30914e-05
|
|
|
THY1
|
[NCBI]
|
3.21875e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
3.10969e-05
|
|
|
ACPP
|
[NCBI]
|
3.08976e-05
|
|
|
GAD2
|
[NCBI]
|
3.03047e-05
|
|
|
CEACAM6
|
[NCBI]
|
3.03047e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
3.01818e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
2.93144e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.84905e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
2.84905e-05
|
|
|
AR
|
[NCBI]
|
2.77796e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
2.77061e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.74266e-05
|
|
|
RPP30
|
[NCBI]
|
2.63966e-05
|
|
|
SUCLG1
|
[NCBI]
|
2.63966e-05
|
|
|
FOLR3
|
[NCBI]
|
2.63966e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
2.55598e-05
|
|
|
IL18
|
[NCBI]
|
2.49209e-05
|
|
|
SPDA1
|
[NCBI]
|
2.49047e-05
|
|
|
TNF
|
[NCBI]
|
2.48787e-05
|
|
|
NPPA
|
[NCBI]
|
2.4777e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
2.4276e-05
|
|
|
LSA
|
[NCBI]
|
2.36721e-05
|
|
|
SNAPC2
|
[NCBI]
|
2.33013e-05
|
|
|
GLULD1
|
[NCBI]
|
2.33013e-05
|
|
|
DPYSL5
|
[NCBI]
|
2.33013e-05
|
|
|
PIP5K1A
|
[NCBI]
|
2.33013e-05
|
|
|
COPB2
|
[NCBI]
|
2.33013e-05
|
|
|
RPP38
|
[NCBI]
|
2.33013e-05
|
|
|
HLA-DRB5
|
[NCBI]
|
2.33013e-05
|
|
|
INHBA
|
[NCBI]
|
2.32812e-05
|
|
|
RNASE2
|
[NCBI]
|
2.25031e-05
|
|
|
fucosidosis
|
[NCBI]
|
2.213e-05
|
|
|
CRYZ
|
[NCBI]
|
2.12973e-05
|
|
|
GNAZ
|
[NCBI]
|
2.12973e-05
|
|
|
alkaline phosphatase, intestinal, fetal form
|
[NCBI]
|
2.12973e-05
|
|
|
KIF23
|
[NCBI]
|
2.12973e-05
|
|
|
CENPF
|
[NCBI]
|
2.12973e-05
|
|
|
FBLN2
|
[NCBI]
|
2.12973e-05
|
|
|
GGPS1
|
[NCBI]
|
2.12973e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
2.12973e-05
|
|
|
SDC2
|
[NCBI]
|
2.11093e-05
|
|
|
sandhoff disease
|
[NCBI]
|
2.09702e-05
|
|
|
TGM5
|
[NCBI]
|
1.98118e-05
|
|
|
GABPB
|
[NCBI]
|
1.98118e-05
|
|
|
HPA-2
|
[NCBI]
|
1.98118e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
1.97091e-05
|
|
|
DSG3
|
[NCBI]
|
1.94957e-05
|
|
|
HDC
|
[NCBI]
|
1.91669e-05
|
|
|
SOD2
|
[NCBI]
|
1.91001e-05
|
|
|
GC
|
[NCBI]
|
1.89017e-05
|
|
|
HSAN3
|
[NCBI]
|
1.78781e-05
|
|
|
MCP
|
[NCBI]
|
1.77351e-05
|
|
|
PTPRN2
|
[NCBI]
|
1.76529e-05
|
|
|
UGT2B4
|
[NCBI]
|
1.76529e-05
|
|
|
CTNNA2
|
[NCBI]
|
1.76529e-05
|
|
|
CFTR
|
[NCBI]
|
1.762e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.74881e-05
|
|
|
tl antigen
|
[NCBI]
|
1.68178e-05
|
|
|
NASP
|
[NCBI]
|
1.68178e-05
|
|
|
SLC25A13
|
[NCBI]
|
1.68178e-05
|
|
|
SNCB
|
[NCBI]
|
1.68178e-05
|
|
|
INADL
|
[NCBI]
|
1.68178e-05
|
|
|
APLN
|
[NCBI]
|
1.68178e-05
|
|
|
CYP4A11
|
[NCBI]
|
1.68178e-05
|
|
|
RPL7
|
[NCBI]
|
1.68178e-05
|
|
|
PCNA
|
[NCBI]
|
1.65614e-05
|
|
|
CCL2
|
[NCBI]
|
1.6276e-05
|
|
|
GNRH1
|
[NCBI]
|
1.6231e-05
|
|
|
GABPA
|
[NCBI]
|
1.60898e-05
|
|
|
HSPA8
|
[NCBI]
|
1.60898e-05
|
|
|
HEMB
|
[NCBI]
|
1.57642e-05
|
|
|
FSHR
|
[NCBI]
|
1.56854e-05
|
|
|
CBX1
|
[NCBI]
|
1.54451e-05
|
|
|
DSG4
|
[NCBI]
|
1.54451e-05
|
|
|
GPX4
|
[NCBI]
|
1.54451e-05
|
|
|
VCL
|
[NCBI]
|
1.54451e-05
|
|
|
OXT
|
[NCBI]
|
1.51476e-05
|
|
|
ALPI
|
[NCBI]
|
1.48668e-05
|
|
|
KLK3
|
[NCBI]
|
1.44519e-05
|
|
|
SAG
|
[NCBI]
|
1.43429e-05
|
|
|
BDNF
|
[NCBI]
|
1.41091e-05
|
|
|
AFP
|
[NCBI]
|
1.39453e-05
|
|
|
SPN
|
[NCBI]
|
1.38642e-05
|
|
|
hurler syndrome
|
[NCBI]
|
1.3834e-05
|
|
|
HLA-A
|
[NCBI]
|
1.35246e-05
|
|
|
GRIN2B
|
[NCBI]
|
1.34237e-05
|
|
|
ZP3
|
[NCBI]
|
1.34237e-05
|
|
|
XG
|
[NCBI]
|
1.34237e-05
|
|
|
GDF15
|
[NCBI]
|
1.34237e-05
|
|
|
VIP
|
[NCBI]
|
1.31467e-05
|
|
|
PYY
|
[NCBI]
|
1.30736e-05
|
|
|
PRPH
|
[NCBI]
|
1.30161e-05
|
|
|
SUMO1
|
[NCBI]
|
1.30161e-05
|
|
|
GGH
|
[NCBI]
|
1.30161e-05
|
|
|
homocystinuria
|
[NCBI]
|
1.29764e-05
|
|
|
F3
|
[NCBI]
|
1.27912e-05
|
|
|
POLD1
|
[NCBI]
|
1.22824e-05
|
|
|
GRIN2A
|
[NCBI]
|
1.22824e-05
|
|
|
MAN2B1
|
[NCBI]
|
1.19499e-05
|
|
|
IL15
|
[NCBI]
|
1.19499e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.17385e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.16369e-05
|
|
|
SRC
|
[NCBI]
|
1.16036e-05
|
|
|
PC
|
[NCBI]
|
1.14245e-05
|
|
|
SPR
|
[NCBI]
|
1.13413e-05
|
|
|
PCI
|
[NCBI]
|
1.13364e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
1.10614e-05
|
|
|
PI3
|
[NCBI]
|
1.07956e-05
|
|
|
HPRT1
|
[NCBI]
|
1.05834e-05
|
|
|
DLK1
|
[NCBI]
|
1.05428e-05
|
|
|
JUN
|
[NCBI]
|
1.05428e-05
|
|
|
CPM
|
[NCBI]
|
1.05428e-05
|
|
|
FUS
|
[NCBI]
|
1.05428e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
1.05428e-05
|
|
|
LPL
|
[NCBI]
|
1.05336e-05
|
|
|
IAPP
|
[NCBI]
|
1.03075e-05
|
|
|
EEF2
|
[NCBI]
|
1.03017e-05
|
|
|
RPS6KA5
|
[NCBI]
|
1.03017e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.00573e-05
|
|
|
VDR
|
[NCBI]
|
9.86941e-06
|
|
|
HLA-DRB1
|
[NCBI]
|
9.85102e-06
|
|
|
HK1
|
[NCBI]
|
9.85102e-06
|
|
|
pta deficiency
|
[NCBI]
|
9.63981e-06
|
|
|
LDHB
|
[NCBI]
|
9.63981e-06
|
|
|
BMP15
|
[NCBI]
|
9.63981e-06
|
|
|
PF4
|
[NCBI]
|
9.63601e-06
|
|
|
CD44
|
[NCBI]
|
9.43708e-06
|
|
|
DDC
|
[NCBI]
|
9.39948e-06
|
|
|
PRG4
|
[NCBI]
|
9.24222e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
9.0547e-06
|
|
|
SLC3A2
|
[NCBI]
|
9.0547e-06
|
|
|
CHGA
|
[NCBI]
|
8.87402e-06
|
|
|
TNFSF8
|
[NCBI]
|
8.87402e-06
|
|
|
GCDH
|
[NCBI]
|
8.69974e-06
|
|
|
HMBS
|
[NCBI]
|
8.55773e-06
|
|
|
GLB1
|
[NCBI]
|
8.05914e-06
|
|
|
TNFSF13B
|
[NCBI]
|
7.91152e-06
|
|
|
NTRK2
|
[NCBI]
|
7.76838e-06
|
|
|
PDGFB
|
[NCBI]
|
7.76838e-06
|
|
|
FN1
|
[NCBI]
|
7.62946e-06
|
|
|
HDGF
|
[NCBI]
|
7.49457e-06
|
|
|
PTPRC
|
[NCBI]
|
7.49457e-06
|
|
|
wolman disease
|
[NCBI]
|
7.49457e-06
|
|
|
RNASE3
|
[NCBI]
|
7.42744e-06
|
|
|
C4B
|
[NCBI]
|
7.36349e-06
|
|
|
DSG1
|
[NCBI]
|
7.36349e-06
|
|
|
RHCE
|
[NCBI]
|
7.36349e-06
|
|
|
PKLR
|
[NCBI]
|
7.36349e-06
|
|
|
GNMT
|
[NCBI]
|
7.23603e-06
|
|
|
UMOD
|
[NCBI]
|
7.23603e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
6.99134e-06
|
|
|
CTLA4
|
[NCBI]
|
6.99134e-06
|
|
|
HLA-DRA
|
[NCBI]
|
6.99134e-06
|
|
|
TF
|
[NCBI]
|
6.7993e-06
|
|
|
APS1
|
[NCBI]
|
6.79776e-06
|
|
|
EPO
|
[NCBI]
|
6.78034e-06
|
|
|
POLG
|
[NCBI]
|
6.75923e-06
|
|
|
USF1
|
[NCBI]
|
6.75923e-06
|
|
|
fabry disease
|
[NCBI]
|
6.65975e-06
|
|
|
factor x deficiency
|
[NCBI]
|
6.43235e-06
|
|
|
IFNG
|
[NCBI]
|
6.43235e-06
|
|
|
PZP
|
[NCBI]
|
6.43235e-06
|
|
|
TPT1
|
[NCBI]
|
6.43235e-06
|
|
|
ALAD
|
[NCBI]
|
6.32859e-06
|
|
|
DAO
|
[NCBI]
|
6.03153e-06
|
|
|
krabbe disease
|
[NCBI]
|
6.00616e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
5.76079e-06
|
|
|
TFPI2
|
[NCBI]
|
5.66534e-06
|
|
|
INSL3
|
[NCBI]
|
5.66534e-06
|
|
|
TFRC
|
[NCBI]
|
5.66534e-06
|
|
|
OTC
|
[NCBI]
|
5.66534e-06
|
|
|
PTH
|
[NCBI]
|
5.58866e-06
|
|
|
DCC
|
[NCBI]
|
5.49372e-06
|
|
|
SLC2A2
|
[NCBI]
|
5.41055e-06
|
|
|
ADA
|
[NCBI]
|
5.20948e-06
|
|
|
ACHE
|
[NCBI]
|
5.13222e-06
|
|
|
UGT1A1
|
[NCBI]
|
4.94498e-06
|
|
|
GDNF
|
[NCBI]
|
4.88272e-06
|
|
|
PRLH
|
[NCBI]
|
4.87251e-06
|
|
|
APRT
|
[NCBI]
|
4.27667e-06
|
|
|
MS
|
[NCBI]
|
4.26629e-06
|
|
|
FGA
|
[NCBI]
|
4.21577e-06
|
|
|
SPP1
|
[NCBI]
|
4.18876e-06
|
|
|
APOB
|
[NCBI]
|
4.16645e-06
|
|
|
HP
|
[NCBI]
|
4.12114e-06
|
|
|
NGFB
|
[NCBI]
|
3.98073e-06
|
|
|
SNCA
|
[NCBI]
|
3.92745e-06
|
|
|
ASS
|
[NCBI]
|
3.66157e-06
|
|
|
LCT
|
[NCBI]
|
3.56092e-06
|
|
|
TH
|
[NCBI]
|
3.55136e-06
|
|
|
AVP
|
[NCBI]
|
3.43759e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
3.36861e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
3.36861e-06
|
|
|
FGF1
|
[NCBI]
|
3.18744e-06
|
|
|
ABCB11
|
[NCBI]
|
3.0165e-06
|
|
|
PAEP
|
[NCBI]
|
2.97527e-06
|
|
|
CCK
|
[NCBI]
|
2.93978e-06
|
|
|
PRL
|
[NCBI]
|
2.92837e-06
|
|
|
NSF
|
[NCBI]
|
2.85499e-06
|
|
|
GPI
|
[NCBI]
|
2.84835e-06
|
|
|
ALB
|
[NCBI]
|
2.81525e-06
|
|
|
SLC6A3
|
[NCBI]
|
2.69621e-06
|
|
|
SI
|
[NCBI]
|
2.6653e-06
|
|
|
CALCRL
|
[NCBI]
|
2.59296e-06
|
|
|
LDLR
|
[NCBI]
|
2.25487e-06
|
|
|
LPO
|
[NCBI]
|
2.22763e-06
|
|
|
SPINK1
|
[NCBI]
|
2.10716e-06
|
|
|
GFAP
|
[NCBI]
|
2.07504e-06
|
|
|
IGFALS
|
[NCBI]
|
1.99266e-06
|
|
|
APOE
|
[NCBI]
|
1.96508e-06
|
|
|
COMT
|
[NCBI]
|
1.90925e-06
|
|
|
ADCYAP1
|
[NCBI]
|
1.77592e-06
|
|
|
TBP
|
[NCBI]
|
1.65748e-06
|
|
|
MPO
|
[NCBI]
|
1.53684e-06
|
|
|
VASP
|
[NCBI]
|
1.3918e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
1.28067e-06
|
|
|
TERT
|
[NCBI]
|
1.27263e-06
|
|
|
G6PD
|
[NCBI]
|
1.19141e-06
|
|
|
EGF
|
[NCBI]
|
1.09689e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.08999e-06
|
|
|
PTHLH
|
[NCBI]
|
1.05902e-06
|
|
|
KITLG
|
[NCBI]
|
1.05836e-06
|
|
|
MUC1
|
[NCBI]
|
9.93634e-07
|
|
|
XDH
|
[NCBI]
|
9.75286e-07
|
|
|
APP
|
[NCBI]
|
9.62173e-07
|
|
|
DHFR
|
[NCBI]
|
9.58253e-07
|
|
|
CRH
|
[NCBI]
|
9.23341e-07
|
|
|
CHAT
|
[NCBI]
|
8.45853e-07
|
|
|
CJD
|
[NCBI]
|
8.38039e-07
|
|
|
CD
|
[NCBI]
|
6.9961e-07
|
|
|
SST
|
[NCBI]
|
6.87286e-07
|
|
|
DMD
|
[NCBI]
|
6.05881e-07
|
|
|
ALK
|
[NCBI]
|
5.94822e-07
|
|
|
PRNP
|
[NCBI]
|
5.21202e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
4.93117e-07
|
|
|
ACE
|
[NCBI]
|
3.97454e-07
|
|
|
CYP1A1
|
[NCBI]
|
3.57865e-07
|
|
|
SRF
|
[NCBI]
|
3.32618e-07
|
|
|
MB
|
[NCBI]
|
2.76967e-07
|
|
|
GAPDH
|
[NCBI]
|
2.7011e-07
|
|
|
ABCC1
|
[NCBI]
|
2.42214e-07
|
|
|
IL2
|
[NCBI]
|
2.30045e-07
|
|
|
POMC
|
[NCBI]
|
1.07607e-07
|
|
|
NPY
|
[NCBI]
|
1.07402e-07
|
|
|
GHRH
|
[NCBI]
|
8.27513e-08
|
|
|
ACP5
|
[NCBI]
|
7.92865e-08
|
|
|
PNMT
|
[NCBI]
|
6.65526e-08
|
|
|
PI
|
[NCBI]
|
5.5382e-08
|
|
|
OSM
|
[NCBI]
|
2.41627e-08
|
|
|
CP
|
[NCBI]
|
4.42603e-09
|
|